Aegis Therapeutics LLC, a US-based drug delivery technology company, has obtained New Zealand patent providing coverage through December 2029 for fast acting formulations of triptans. The New Zealand patent is the third patent awarded to ...
Tags: Aegis, Fast Acting Formulations